ERBB2 and metastasis: As shown in Figure 4A which represented only one metastasis site, the difference on CSS could be found only in patients with HR+/HER2- (χ2=29.70, P<0.001) or HR-/HER2+ (χ2=8.461, P=0.0374), and the patients with brain metastasis still had worst CSS.